Algeria Explores Regional Hub for African Medicine Supply

الجزائر تبحث إنشاء مركز إقليمي لتموين إفريقيا بالأدوية الأساسية المحلية
Photo via Echoroukonline

Algeria's Minister of Pharmaceutical Industry, Wacim Guédri, chaired a significant technical meeting on Thursday, September 03, 2026, at the Ministry's headquarters. The primary objective of this gathering was to discuss strengthening international cooperation in the key area of supplying essential medicines across the African continent. The meeting brought together key international partners, including Katarina Johansson, the representative of the UNICEF office in Algeria, Fanuel Happimana, the WHO representative in Algeria, and Hassiba Saih, the representative of the UNIDO office. These representatives engaged in detailed discussions focused on enhancing collaborative efforts and forging stronger partnerships to ensure a stable and efficient supply chain for critical medications throughout the region. The emphasis was placed on developing strong mechanisms to address the pharmaceutical needs of African nations, thereby contributing to improved public health outcomes.

Building on Past Initiatives

This current meeting serves as a direct continuation and builds significantly on a prior technical mission undertaken by Algeria's Minister of Pharmaceutical Industry, Wacim Guédri. In July, Minister Guédri traveled to the UNICEF supply division in Copenhagen, Denmark. The core purpose of Guédri's mission was to thoroughly study the project for establishing a regional center specifically dedicated to supplying essential medicines. This proposed center would leverage pharmaceutical products manufactured locally within Algeria, aiming to create a self-sufficient and resilient supply network.

This initiative also follows up on the important outcomes derived from the African Ministerial Conference on Local Production of Medicines and Health Technologies. This key conference took place in Algiers in November 2025, bringing together ministerial representatives from across the continent. A key achievement of that conference was the unanimous adoption of the "Algiers Declaration." The Algiers Declaration is a full document that outlines several strategic initiatives specifically intended to strengthen integration and foster deeper cooperation among African countries. These initiatives are centered on boosting local medicine production capabilities and enhancing health technology development across the continent, laying a foundation for greater pharmaceutical independence.

Strategic Meeting Details and Future Roadmaps

Participants in the recent meeting at the Ministry's headquarters showed the critical necessity of adopting a joint roadmap. This proposed roadmap is envisioned to be a practical guide, incorporating concrete measures and actionable steps designed for both the short and medium term. To ensure structured progress, a joint work calendar for the period 2026-2027 was formally proposed as an integral part of these collaborative efforts. The discussions also heavily emphasized the ongoing importance of consistently strengthening coordination, fostering deeper cooperation, and solidifying strategic partnerships between Algeria and its various international partners. This sustained collaboration is deemed essential to effectively translate the ambitious outcomes and recommendations from the African Ministerial Conference on Local Production of Medicines and Health Technologies into tangible, impactful projects and initiatives that can be implemented across the region. The aim is to move beyond declarations to concrete actions that benefit African populations.

Continental Health Security Vision

The overarching and ambitious goal driving all these initiatives is to commence supplying African markets with essential medicines that are produced locally within Algeria. This strategic effort is designed to significantly enhance Algeria's role as a key contributor in supporting the health and pharmaceutical security of the entire African continent. By focusing on bolstering local production capabilities within Algeria, the initiative intends to contribute directly to the establishment of a more stable, reliable, and resilient supply chain for critical medications across the region. This forward-looking strategy aligns perfectly with broader continental objectives aimed at strengthening regional self-sufficiency in pharmaceutical supplies, reducing reliance on external sources, and ultimately improving access to life-saving medicines for millions of people.